Forex Education Symbols

(TSX = xxx.TO, TSX-V = xxx.V)

1.65 -0.01 (-0.60%) 10/20/2017 12:42pm
Open: 1.66 Prev Close: 1.66
High: 1.66 Low: 1.65
Volume: 1300 Market Cap: 24.27M
Year High: 3.32 Year Low: 1.47
Stock Technical Analysis
Targets Six months: 2.12    One year: 2.30
Supports Support1: 1.57   Support2: 1.31
Resistances Resistance1: 1.82    Resistance2: 1.97 
Pivot Point 1.69 
Moving Averages MA(5): 1.66      MA(20): 1.67 

MA(100): 1.66      MA(250): 1.71 
MACD MACD(12,26): 0.01      Signal(12,26,9): 0.01 
Stochastic Oscillator %K(14,3): 11.11      %D(3): 12.65 
RSI RSI(14): 48.15 
52-Week High: 3.32  Low: 1.47  Change(%): -20.7
Average Volume(K) 3-Month: 455  10-Days: 3
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
ACST.V has closed above bottom band by 27.9%. Bollinger Bands are 13.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock News
Mon, 28 Nov 2016 13:06:08 GMT

Acasti Pharma Inc.
Tue, 08 Jan 2013 00:46:17 GMT

Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock ...
Thu, 17 Aug 2017 03:45:00 GMT

Acasti Pharma Reports Third Quarter 2017 Financial Results
Thu, 12 Jan 2017 22:07:30 GMT

Acasti Pharma Announces Pricing for its Public Offering of Units
Fri, 10 Feb 2017 21:22:30 GMT

Jan D'Alvise Appointed President & CEO of Acasti Pharma
Thu, 12 May 2016 12:00:00 GMT

Stoxline Canada

Stock Chart Toronto

Option Calculator

EPS -0.940
EPS Est. Current Year -0.970
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS 1.#IO
Shares Out. (M) 14.74
Shares Float (M) 8.11
Book Value (p.s.) 1.290
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.531
Qtrly Earnings Growth
Operating Cash Flow (M) -6.42
Levered Free Cash Flow (M)
P/E -1.76
P/E Growth Ratio -0.01
P/BV 1.28
P/CF -3.79